Contact
Please use this form to send email to PR contact of this press release:
EOFlow Receives FDA Breakthrough Device Designation on its Integrated Wearable Automated Insulin Delivery System
TO:
Luis Malave
EOFlow, Inc.
+1 661-644-7539